Neuronetics (STIM) Current Deferred Revenue (2017 - 2026)

Neuronetics (STIM) has 10 years of Current Deferred Revenue data on file, last reported at $833000.0 in Q1 2026.

• On a quarterly basis, Current Deferred Revenue rose 6.11% year-over-year to $833000.0 in Q1 2026; TTM through Mar 2026 was $833000.0, a 6.11% increase from a year earlier, with the FY2025 full-year figure at $753000.0, down 22.69% from the prior year.
• Current Deferred Revenue for Q1 2026 stood at $833000.0, up from $753000.0 in the prior quarter.
• Over the last five years, Current Deferred Revenue for STIM reached as high as $2.0 million in Q4 2022 and fell as low as $753000.0 in Q4 2025.
• Historically, Current Deferred Revenue has averaged $1.4 million across 5 years, with a median of $1.6 million in 2023.
• Across the five-year window, Current Deferred Revenue plunged 51.63% in 2025 and gained 6.11% in 2026, its largest moves.
• Year by year, Current Deferred Revenue stood at $2.0 million in 2022, then fell by 18.18% to $1.6 million in 2023, then sank by 39.88% to $974000.0 in 2024, then declined by 22.69% to $753000.0 in 2025, then gained by 10.62% to $833000.0 in 2026.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $833000.0 in Q1 2026, $753000.0 in Q4 2025, and $754000.0 in Q3 2025.